EDGAR Filing Documents for 0001213900-24-017157

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001213900-24-017157

Filing Date

2024-02-27

Accepted

2024-02-27 08:27:59

Documents

Period of Report

2024-02-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM 8-K	ea193847-8ka1_cerothera.htm iXBRL	8-K/A	203817
2	SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CERO THERAPEUTICS HO	ea193847ex3-1_cerothera.htm	EX-3.1	35618
3	SECOND AMENDED AND RESTATED BYLAWS OF CERO THERAPEUTICS HOLDINGS, INC	ea193847ex3-2_cerothera.htm	EX-3.2	187288
4	CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES	ea193847ex3-3_cerothera.htm	EX-3.3	292364
5	CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS A	ea193847ex3-4_cerothera.htm	EX-3.4	288524
6	SECOND CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATION OF PREFERENCES, R	ea193847ex3-5_cerothera.htm	EX-3.5	345927
7	FORM OF COMMON WARRANT	ea193847ex4-2_cerothera.htm	EX-4.2	156085
8	FORM OF PREFERRED WARRANT	ea193847ex4-3_cerothera.htm	EX-4.3	114629
9	DESCRIPTION OF SECURITIES	ea193847ex4-5_cerothera.htm	EX-4.5	91402
10	CERO THERAPEUTICS HOLDINGS, INC. 2024 EQUITY INCENTIVE PLAN	ea193847ex10-2_cerothera.htm	EX-10.2	198761
11	CERO THERAPEUTICS HOLDINGS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN	ea193847ex10-3_cerothera.htm	EX-10.3	92231
12	INVESTOR RIGHTS AND LOCK-UP AGREEMENT, DATED FEBRUARY 14, 2024, BY AND BETWEEN P	ea193847ex10-5_cerothera.htm	EX-10.5	188483
13	AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT, DATED AS OF FEBRUARY 14, 202	ea193847ex10-6_cerothera.htm	EX-10.6	458941
14	REGISTRATION RIGHTS AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN PHO	ea193847ex10-7_cerothera.htm	EX-10.7	140409
15	COMMON STOCK PURCHASE AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN C	ea193847ex10-8_cerothera.htm	EX-10.8	425089
16	REGISTRATION RIGHTS AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN CER	ea193847ex10-9_cerothera.htm	EX-10.9	110303
17	FORM OF SHARE REALLOCATION AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND AMON	ea193847ex10-10_cerothera.htm	EX-10.10	69819
18	LETTER AGREEMENT, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN PHOENIX BIOTECH	ea193847ex10-11_cerothera.htm	EX-10.11	24311
19	SIDE LETTER, DATED AS OF FEBRUARY 14, 2024, BY AND BETWEEN PHOENIX BIOTECH ACQUI	ea193847ex10-12_cerothera.htm	EX-10.12	15304
20	LIST OF SUBSIDIARIES OF CERO THERAPEUTICS HOLDINGS, INC	ea193847ex21-1_cerothera.htm	EX-21.1	2217
21	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF CERO THERAPEUTIC	ea193847ex99-1_cerothera.htm	EX-99.1	245727
	Complete submission text file	0001213900-24-017157.txt		4767440

Data Files

Seq	Description	Document	Type	Size
22	XBRL SCHEMA FILE	pbax-20240213.xsd	EX-101.SCH	3893
23	XBRL DEFINITION FILE	pbax-20240213_def.xml	EX-101.DEF	28829
24	XBRL LABEL FILE	pbax-20240213_lab.xml	EX-101.LAB	38680
25	XBRL PRESENTATION FILE	pbax-20240213_pre.xml	EX-101.PRE	27038
36	EXTRACTED XBRL INSTANCE DOCUMENT	ea193847-8ka1_cerothera_htm.xml	XML	8457

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080

Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376

CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)